Publikationen, an denen er mitarbeitet Camino Gutiérrez Corbo (15)

2022

  1. Axenic interspecies and intraclonal hybrid formation in Leishmania: Successful crossings between visceral and cutaneous strains

    PLoS neglected tropical diseases, Vol. 16, Núm. 2, pp. e0010170

2021

  1. Bioluminescent Imaging Identifies Thymus, As Overlooked Colonized Organ, in a Chronic Model of Leishmania donovani Mouse Visceral Leishmaniasis

    ACS Infectious Diseases, Vol. 7, Núm. 4, pp. 871-883

  2. Ex Vivo Phenotypic Screening of Two Small Repurposing Drug Collections Identifies Nifuratel as a Potential New Treatment against Visceral and Cutaneous Leishmaniasis

    ACS Infectious Diseases, Vol. 7, Núm. 8, pp. 2390-2401

  3. Reproduction in trypanosomatids: Past and present

    Biology, Vol. 10, Núm. 6

2020

  1. DNA flowerstructure co-localizes with human pathogens in infected macrophages

    Nucleic acids research, Vol. 48, Núm. 11, pp. 6081-6091

  2. Mannose-decorated dendritic polyglycerol nanocarriers drive antiparasitic drugs to leishmania infantum-infected macrophages

    Pharmaceutics, Vol. 12, Núm. 10, pp. 1-21

2019

  1. A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery

    PLoS Neglected Tropical Diseases, Vol. 13, Núm. 2

  2. Antiparasitic effect of synthetic aromathecins on Leishmania infantum

    BMC Veterinary Research, Vol. 15, Núm. 1

  3. Current and promising novel drug candidates against visceral leishmaniasis

    Pure and Applied Chemistry

  4. In vitro anthelmintic activity and safety of different plant species against the ovine gastrointestinal nematode Teladorsagia circumcincta

    Research in Veterinary Science, Vol. 123, pp. 153-158

  5. Topoisomerase IB poisons induce histone H2A phosphorylation as a response to DNA damage in Leishmania infantum

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 11, pp. 39-48

  6. Walking a tightrope: drug discovery in visceral leishmaniasis

    Drug Discovery Today, Vol. 24, Núm. 5, pp. 1209-1216

2018

  1. Chapter 17: DNA Topoisomerases as Promising Targets for Leishmania Chemotherapy

    RSC Drug Discovery Series (Royal Society of Chemistry), pp. 348-370

2017

  1. Leishmaniosis canina: actualización de la farmacoterapia

    Consulta de difusión veterinaria, Vol. 25, Núm. 242, pp. 48-54

  2. PEGylated Dendritic Polyglycerol Conjugate Delivers Doxorubicin to the Parasitophorous Vacuole in Leishmania infantum Infections

    Macromolecular Bioscience, Vol. 17, Núm. 10